#biotherapy

[doubtfultaste]

Biotherapy (バイオセラピー) , 1986 

[bpod-bpod]

Neuron Membrane Shaper

Vital role revealed of a BAR domain protein called FAM92A1 in remodelling neuron membranes during brain development, particularly at synapses, the structure that allows passage of signals from one neuron to another. Insight into the risk of FAM92A1 mutation leading to human neurological disorders

Read the published research article here

Image from work by Liang Wang and Ziyun Yang, and colleagues

Mental Health Center & National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, China; Biological & Environmental Sciences, University of Helsinki, Finland

Image originally published with a Creative Commons Attribution 4.0 International (CC BY 4.0)

Published in Nature Communications, July 2024

You can also follow BPoD on Instagram, Twitter and Facebook

[materialsscienceandengineering]

Researchers develop technique to synthesize water-soluble alloy nanoclusters

In recent years, ultrasmall metal nanoclusters have unlocked advances in fields ranging from bioimaging and biosensing to biotherapy, thanks to their unique molecular-like properties. In a study published in the journal Polyoxometalates, a research team from Qingdao University of Science and Technology proposed a design to synthesize atomically precise, water-soluble alloy nanoclusters. "The novelty of this study is in a new strategy for the synthesis of water-soluble alloy nanoclusters and a further contribution to the fundamental understanding of the alloying mechanism of metal nanoclusters," said study author Xun Yuan from Qingdao University of Science and Technology. "The ultimate goal is to develop such alloy nanoclusters as novel nanomedicine," Yuan said.

Read more.

[regenhealthsolutions]

Space: A new frontier for exploring stem cell therapy

Stem cells grown in microgravity aboard the International Space Station (ISS) have unique qualities that could one day help accelerate new biotherapies and heal complex disease, two Mayo Clinic researchers say.  The research analysis by Fay Abdul Ghani and Abba Zubair, M.D., Ph.D., published in NPJ Microgravity, finds microgravity can strengthen the regenerative potential of cells. Dr. Zubair is…

[ubaid455]

Anticipated Size of Cellular Starting Materials Market: $9.00B by 2032, 22.8% CAGR

Leading market research and consulting organization Polaris Market Research is excited to announce the release of its latest research report titled Cellular Starting Materials market. The report highlights the current state and growth potential of the Cellular Starting Materials market. It delves into various aspects of the market, including market share, market size, top trends, and recent developments. Also, it sheds light on the major operating strategies used by market participants to stay competitive in the market. Besides, a thorough analysis of all the major segments and sub-segments has been included in the study.

The research report includes Porter’s Five Forces analysis to examine the competitive landscape within the market. Both quantitative and qualitative analyses have been used in the study to offer an in-depth market comprehension. Also, the report makes use of pictorial representations like graphs and charts to help readers understand the key stats and other information easily. The report is a must-read for anyone looking to make strategic and informed business decisions.

Global Cellular Starting Materials Market size and share is currently valued at USD 1.43 Billion in 2023 and is anticipated to generate an estimated revenue of USD 9.00 Billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 22.8% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 - 2032

Top key players: AcceGen, AllCells, Anthony Nolan, BioIVT, CGT GLOBAL, Charles River Laboratories, Excellos, HumanCells Bio, NMDP BioTherapies., STEMCELL Technologies

Market Dynamics

This section of the research study examines the key forces that affect the performance and behavior of the market. These include:

Supply and Demand: The research study examines the fluctuations in supply and demand and their impact on pricing signals.

Technological Advancements: An examination of all the major technology advancements and innovations and how they are driving market growth have been examined in the study.

Regulatory Changes: The study assesses all the major regulatory changes, policies, and initiatives and how they are influencing market demand.

Consumer Preferences: The impact of consumer behavior and preferences on Cellular Starting Materials market sales has been detailed in the research report.

Economic Trends: The sheds light on all the major economic trends worldwide that can affect the market dynamics.

Browse Full Insights:

Market Segmentation

This section of the research study divides the market into meaningful subgroups based on common characteristics. The Cellular Starting Materials market segmentation is primarily based on type, application, end-use, and region. By understanding market segmentation, businesses can create effective targeted advertising and promotions that resonate with every group. Also, it can help save time and money by avoiding mass marketing techniques that may not be effective for specific groups. Besides, businesses can collect valuable feedback from every group to improve their products/services. What’s more, segmental analysis can improve business focus by enabling them to make better decisions about location, inventory, and hiring.

Competitive Landscape

The competitive landscape examines the current state of competition in the market. It assesses all the major companies that compete with a specific company for customers. Also, it examines the options available to customers instead of the company’s products/services. Competitive landscape analysis includes several factors, including the number of competitors and their market share, product offerings, and pricing strategies. Also, it sheds light on the level of competition and major Cellular Starting Materials market trends. By going through the competitive landscape section, businesses can identify potential opportunities and avoid costly mistakes. Furthermore, it can assist stakeholders in capitalizing on new ideas and improving their customer journey.

Regional Analysis

Regional analysis involves the study of specific geographic regions in the Cellular Starting Materials market. It helps examine the impact of social, physical, and economic variables in a regional context. Also, it assists businesses in understanding consumer behavior, economic trends, and competitive landscapes. Regional analysis is important for stakeholders, businesses, analysts, and policymakers to assess the market state in various market regions and sub-regions across the globe.

The key regions and sub-regions covered in the research report are:

North America (US, Canada)

Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)

Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)

Latin America (Brazil, Mexico, Argentina)

Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

The Report Answers Questions Such As:

What is the current market size and forecast market value?

What is the estimated CAGR for the market over the forecast period?

Which region is projected to witness substantial Cellular Starting Materials market growth?

Which segment is anticipated to lead the market?

What are the emerging business opportunities for market players?

What can strategic developments take the market in the upcoming years?

More Trending Latest Reports By Polaris Market Research:

Powder Coating Equipment Market

Cloning and Mutagenesis Market

U.S. Immunoassay Market

Power Rental Market

Linear LED Strip Fixture Market

[healthcarehubhh]

The Global Amniotic Membrane Market will grow at highest pace owing to rising aging population.

Amniotic Membrane or amnion refers to the innermost layer of the placenta. It acts as a physical barrier between the fetus and the mother's uterus. Amniotic membrane finds wide application in wound healing and surgical reconstruction owing to its anti-inflammatory, anti-scarring, and anti-angiogenic properties. It is used in treatments involving burns, skin injuries, ophthalmic defects, and chronic non-healing ulcers. The growing geriatric population suffering from chronic diseases and wounds has increased the demand for amniotic membrane products in wound management. The Global Amniotic Membrane Market is estimated to be valued at US$ 3.62 Bn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030. Key Takeaways Key players operating in the Amniotic Membrane market are Smith & Nephew, Applied Biologics, Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, Next Biosciences, Integra LifeSciences, MiMedx, LifeCell International, Human Regenerative Technologies, LLC, Amniox Medical, Inc, Skye Biologics Inc., Wright Medical, TissueTech, Katena Products, Inc., NuVision Biotherapies, Surgenex, and Ventris Medical. The growing aging population and increase in chronic wounds has augmented the demand for amniotic membrane products. Technological advancements such as development of micronized and acellular amniotic membranes formulations have expanded the application scope of amniotic membranes. Market Trends Cryopreservation of Amniotic Membranes - Cryopreservation allows for long-term storage of amniotic membranes at sub-zero temperatures while maintaining viability and key properties. This enables stockpiling and just-in-time delivery of amniotic membranes to clinics and hospitals. Micronization of Amniotic Membranes - Micronization is the process of comminuting amniotic membranes into micron-sized powder. This improves handling, storage, and delivers concentrated growth factors effectively to target sites. Micronized amniotic membranes have applications in wound healing and regenerative medicine. Market Opportunities Rising Aging Population - The growing geriatric population prone to chronic wounds, burns, and non-healing injuries will drive the demand for amniotic membrane products in wound management over the forecast period. Expanding Applications in Regenerative Medicine - Increased research on regenerative potential of amniotic membranes is extending their use in treatment of degenerative ocular surface diseases, lower urinary tract conditions, musculoskeletal disorders thereby opening new opportunities. Impact of COVID-19 on Amniotic Membrane Market: The COVID-19 pandemic posed significant challenges to the amniotic membrane market. During the early phases of the pandemic, restrictions on non-essential medical procedures led to supply chain disruptions and uncertainties around product availability. Manufacturers faced challenges in sourcing raw materials and maintaining continuous production due to lockdowns and social distancing measures. Movement restrictions also impacted the delivery of products to customers. The focus of healthcare resources on critical COVID-19 patients resulted in delays and postponements of other medical procedures that utilize amniotic membrane products. This adversely affected market demand in the short term.

[crimsonpublishersnutrition]

Nutritional Biotherapy

The ability of food to bring health or illness was already known since ancient times. In the 4th century BC Hippocrates said that food would be our medicine. Even most of the precepts of the Salerno medical school consisted of dietary suggestions. However, it has only been for a few decades that science has been tackling the study of nutrition in an ever more profound manner. The proliferation of many studies is offering us an increasingly broader image of the therapeutic capabilities of individual foods and therefore of the importance of nutrition on the balance of the state of health or disease. All this research offers us a much broader picture of nutrition, which is no longer seen in exclusively quantitative terms, with the measurement of the major nutrients or calories, which must satisfy our energy needs, but with the ability to influence everything metabolism and therefore on the causes of disease themselves.

Read more about this article: https://crimsonpublishers.com/ntnf/fulltext/NTNF.000666.php

Read more articles: https://crimsonpublishers.com/ntnf/index.php

[healthcaremarketanalysis]

Global Therapeutic Drug Monitoring Market worth $2.9 billion by 2027

Therapeutic Drug Monitoring Market in terms of revenue was estimated to be worth $1.8 billion in 2022 and is poised to reach $2.9 billion by 2027, growing at a CAGR of 9.6% from 2022 to 2027 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by the Increasing incidence of chronic and infectious diseases and growing awareness about early disease diagnosis. However, Alternatives to conventional TDM may challenge the growth of this market.

Download PDF Brochure:

Browse in-depth TOC on "Antiepileptic Drug Monitoring Industry"

178 - Tables

50 - Figures

221 – Pages

Germany in European Antibiotic Therapeutic drug monitoring market to witness the highest shares during the forecast period.

The Europe Therapeutic Drug Monitoring Market is segmented into Germany, Italy, France, Spain, the UK, and the Rest of Europe. Germany is projected to occupy the highest share during the forecast period. The major factors contributing to the growth of this market are the rising geriatric population, increasing incidence of chronic and infectious diseases, rising healthcare expenditure, and increasing R&D investments.

Japan dominates the Asia Pacific Immunosuppressant Drug Monitoring industry

The APAC Therapeutic Drug Monitoring market is segmented into Japan, China, and India. In 2021, Japan accounted for the largest share of the Asian Therapeutic Drug Monitoring market. The large share of Japan can be attributed to the large geriatric population in the country, the rising prevalence of chronic medical conditions such as cancer, growing budgetary allocations for healthcare, and the presence of a well-developed healthcare system.

chemiluminescence immunoassays (CLIAs) in the product's immunoassay therapeutic drug monitoring segment to witness the highest growth as well as the largest share in the therapeutic drug monitoring market during the forecast period.

The market is divided into chemiluminescence immunoassays, colorimetric immunoassays, fluorescence immunoassays, radioimmunoassays, and other immunoassays based on the immunoassay. The chemiluminescence immunoassays segment is projected to grow at the highest CAGR during the forecast period because these assays are commonly used in TDM in either enzyme-amplified or direct chemiluminescence measurements.

Request 10% Customization:

Antiarrhythmic Drug Monitoring Industry Dynamics:

Drivers:

Importance of TDM in organ transplant procedures

Use of TDM across various therapeutic fields

Increasing preference for precision medicine

Growing focus on R&D related to TDM

Technological advancements

Restraints:

Requirement of high capital investments

Reluctance of small hospitals to offer TDM services

Opportunities:

Increasing adoption in the treatment of autoimmune diseases

Challenges:

Alternatives to conventional TDM

Operational barriers faced in conducting TDM

Key Market Players:

The significant players in the Therapeutic Drug Monitoring industry are Abbott (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), Danaher Corporation (US), Bio-Rad Laboratories (US), bioMérieux SA (France), Theradiag SA (France), Grifols S.A. (Spain), Exagen Inc. (US), R-Biopharm AG (Germany), ARK Diagnostics, Inc. (US), apDia Group (Belgium), Immundiagnostik AG (Germany), and Sekisui Medical Co. Ltd. (Japan).

Recent Developments:

In May 22, Theradiag (France) Announced the launch of ez-Track1, a Point-of-Care Testing solution for TDM.

In Jan 2021, Theradiag (France) Announced CE marking for four new i-Tracker test kits for biotherapy monitoring.

Report Objectives

To define, describe, and forecast the global Therapeutic Drug Monitoring market based on product, and region

To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)

To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market

To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW)2

To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3

To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the Therapeutic Drug Monitoring market

Frequently Asked Questions (FAQ):

What is the projected market value of the global Therapeutic Drug Monitoring Market?

The global market of Therapeutic Drug Monitoring is projected to reach USD 2.9 billion by 2027.

What is the estimated growth rate (CAGR) of the global Therapeutic Drug Monitoring Market for the next five years?

The global Therapeutic Drug Monitoring market is projected to grow at a Compound Annual Growth Rate (CAGR) of 9.6% from 2022 to 2027.

Who are the major players offering Therapeutic Drug Monitoring in the market?

Abbott (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), Danaher Corporation (US), Bio-Rad Laboratories (US), bioMérieux SA (France), Theradiag SA (France), Grifols S.A. (Spain), Exagen Inc. (US), R-Biopharm AG (Germany)

Who are the significant end users in Therapeutic Drug Monitoring Market?

Hospital laboratories, commercial & private laboratories, are the major end users in Therapeutic Drug Monitoring Market.

Which Immunoassay will have the highest shares in Therapeutic Drug Monitoring Market during the forecast period?

Chemiluminescence Immunoassays will have the highest shares of the Therapeutic Drug Monitoring market during the forecast period

Report Link: ( Therapeutic Drug Monitoring Market )

[doubtfultaste]

Biotherapy (バイオセラピー) , 1986 

[evoldir]

Fwd: Conference: Heraklion_Crete.BiologyAndBiomedicine.Jul20-22

Begin forwarded message: > From: evoldir@evol.biology.mcmaster.ca > Subject: Conference: Heraklion_Crete.BiologyAndBiomedicine.Jul20-22 > Date: 6 April 2024 at 07:00:06 BST > To: rdmpage@gmail.com > > > Dear Author > > You are invited to submit an article in the 4th International Conference > on Biology and Biomedicine - BIOMEDICINE 2024 Heraklion, Crete Island, > Greece. July 20-22, 2024. > https://ift.tt/VlXFMaf > > > Accepted and Presented papers will appear in a Springer Verlag Volume > Computational Problems in Science and Engineering III > Editors: Nikos E. Mastorakis, Imre J. Rudas, Yuriy S. Shmaliy > See our previous volume > https://ift.tt/ZmdFX34 > > > > Best Papers will be published in the following 3 Journals > > > Molecular Biomedicine (Indexed in ISI Web of Science, Scopus etc) > Best papers from the conference will appear in this Journal: > https://ift.tt/Y6vh5W3 > > Editor-in-Chief > Yu-quan Wei, PhD, MD, State Key Laboratory of Biotherapy, West China > Hospital, Sichuan University, China > > > > Biomedical Journal  (Indexed in ISI Web of Science, Scopus etc) > Best papers from the conference will appear in this Journal: > https://ift.tt/JLRClGE > > Editor-in-Chief > Prof. Ming-Ling Kuo, Chang Gung University, Taoyuan, Taiwan > > > WSEAS Transactions on Biology and Biomedicine  (Indexed in  Scopus etc) > Best papers from the conference will appear in this Journal: > https://ift.tt/eEfiolH > > Editor-in-Chief > Prof. Nicholas Tritos, Harvard Medical School, Boston, MA, USA > > Many Thanks > > Kostas Chiotopoulos > > > > "4th International Conference on Biology and Biomedicine - BIOMEDICINE 2024."

[bpod-bpod]

Burrowing Death Cleaners

A newly-discovered function for immune cells called neutrophils as the main clearers of cells undergoing the normal process of programmed death (apoptosis) daily in the liver. Unlike other cell types responsible for clearing the body's apoptosing cells which engulf, these neutrophils burrow in and dispose of the worn-out cell from the inside

Read the published research paper here

Image from work by Lixiang Ma, Juan Zhao and Xiangyu Wang, and colleagues

Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China

Image originally published with a Creative Commons Attribution 4.0 International (CC BY 4.0)

Published in eLife, September 2023

You can also follow BPoD on Instagram, Twitter and Facebook

[shristisahu]

Advancing Glycobiology: Projections and Analysis 2023-2027

Originally Published on: TechnavioGlycobiology Market by Application, Product and Geography - Forecast and Analysis 2023-2027

The Global Glycobiology Market is gearing up for substantial expansion, foreseeing a projected surge of USD 1,473.84 million and an estimated CAGR of 15.06% from 2022 to 2027.

Key Catalysts for Growth

Pharmaceutical and biotechnology sectors are witnessing a notable upswing, propelled by increased R&D activities in glycomics, glycobiology, and proteomics research. Glycobiology is gaining traction in critical areas such as neurobiology, development, immunology, and diverse applications, including biotherapy, antibodies, and heparin analog production.

Carbohydrates intricately bound to glycolipids or glycoproteins play a crucial role in steering the properties and destiny of living cells. The study of glycobiology becomes pivotal in drug discovery, diagnosis, and therapeutic applications, supported by advancements in mass spectrometry for mapping glycan attachment sites and profiling structural variations.

In-Depth Segmentation Analysis

Application Analysis

Drug Discovery and Development: Experiencing substantial growth with the widespread use of glycobiology. Carbohydrates play a pivotal role in biological processes, influencing glycoprotein stability, solubility, and transport.

Product Analysis

Enzymes: Vital in glycobiology, with transferases playing a crucial role in complex carbohydrate generation. These enzymes serve as tools for understanding carbohydrate structure and function.

Instruments: Essential for studying glycans' structure, biology, and function, including microscopes, flow cytometric cell sorting, ELISA, and fluorescent immunohistochemistry. Increasing adoption in disease diagnosis contributes to segment growth.

Regional Analysis

North America is poised to contribute 43% to global market growth, driven by the presence of key pharmaceutical and biopharmaceutical companies, robust healthcare infrastructure, and expanding applications in cancer treatments.

Leading Market Players

Companies deploy diverse strategies like alliances, partnerships, mergers, acquisitions, geographical expansion, and product/service launches. Key players encompass Agilent Technologies Inc., Asparia Glycomics, Bio-Techne Corp, Bruker Corp., CD BioGlyco, Chemily Glycoscience, and more.

Major Drivers, Trends, Challenges, and Customer Landscape

Key Market Drivers

The surge in pharmaceutical companies' R&D expenditure, averaging 15%-20% of revenue, emerges as a significant growth factor. Adoption of pharmaceutical contract packaging minimizes capital and operating costs.

Prominent Market Trends

The escalating demand for glycomics products in drug discovery and development underscores the critical role of glycans in biological processes. Glycans become biomedical hotspots, leading to technological advancements and effective therapies.

Primary Market Challenges

Scarce availability of skilled professionals poses a challenge. Well-trained professionals are imperative for the intricate and risky drug development process in glycobiology.

Customer Landscape

The adoption lifecycle spans from innovators to laggards, encompassing penetration rates in various regions based on key purchase criteria and drivers of price sensitivity.

Segment Overview

The market report predicts revenue growth at global, regional, and country levels, offering insights into trends and opportunities from 2017 to 2027.

Contact us.

[credihealth0]

Cancer doctor in Ranchi for immunotherapy

Immunotherapy involves using certain parts of a person's immune system to fight cancer. It's also called biologic therapy or biotherapy.

It uses substances made by the body or in a laboratory to boost or restore the immune system's ability to fight cancer.

You can find the cancer doctor in Ranchi at HCG Hospital Ranchi.

[medical-angel]

I'm skeptical anyone on biologic therapy long term can function and have a job and shit.

Like, I know I have deteriorating spine disease, which is also a root cause of a lot of my issues, but at the same time I just had a proper treatment after 5 weeks of it clearing from my system and I forgot just how BAD it makes me feel.

My relatives used to expect me to be feeling better THE DAY OF my treatment when I was always exhausted and sick feeling for sometimes days afterwards.

And every source online says "yeah, with a good (and strict!) treatment regimen, even the sickliest of cr*ps can hold down a job and work in The Machine just like their able bodied counterparts!" But like. I wanna hear it from OTHER chronically ill people.

If you have a moderate to severe autoimmune disease, if you take biotherapy by infusion every 6 weeks WITH daily supplemental anti-inflammatory medications, like... tell me how I'm supposed to feel. How do you feel? Can you work, do you work? Is treating the disease actually worth it if you have to be on these infusions for the next 60 years?